Global Nicergoline Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Nicergoline Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Nicergoline is an ergot derivative indicated to treat senile dementia and vascular disorders such as cerebral thrombosis, Raynaud's disease, vascular migraines, atherosclerosis, arterial blockages in the limbs, and retinopathy. It is also indicated for migraines of vascular origin, coadjutant therapy in clinical situations, corio-retinal vascular disorders, oto-vestibular problems. It is sold under the brand name Sermion among others. Nicergoline is a potent vasodilator that helps improve brain blood flow by decreases vascular resistance and improving the utilization of glucose and oxygen by brain cells.
Nicergoline report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nicergoline market is projected to reach US$ 2354.7 million in 2029, increasing from US$ 885 million in 2022, with the CAGR of 16.6% during the period of 2024 to 2029. Demand from Alzheimer's Disease (AD) and Arterial Hypertension are the major drivers for the industry.
The global nicergoline market is projected to grow steadily. The rising burden of vascular disorders worldwide will drive the demand for Nicergoline. Rising incidences of complications due to vascular disorders are anticipated to drive the demand for Nicergoline. Increasing prevalence of cerebral thrombosis, Raynaud's disease, vascular migraines, atherosclerosis, arterial blockages in the limbs, and retinopathy are projected to raise volume calls for Nicergoline. Growing FDA approval for new disease treatments is foreseen to create new growth opportunities. However, the availability of other substitutes in the market is likely to restrain the market growth. Specific challenges are roaming around the market. Adverse events have been noted associated with allergic or hypersensitivity-type reactions after the Nicergoline injection into the body. This may hinder the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nicergoline market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Teva API
FAREVA
Olon Group
Hainan Poly Pharm Co. Ltd
DEAFARMA
Solarium Pharmaceuticals
Fengchen
LGC
Pfizer Pharmaceutical Co., Ltd.
Hebei Lingding Biotechnology Co., Ltd.
Selleck Chemicals
Tocris Bioscience
Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
Shandong Fangming Pharmaceutical Group Co. Ltd.
Hainan General Kangli Pharmaceutical Co. Ltd.
Hainan Zambon Pharmaceutical Co. Ltd
Pharmacia
Shandong Qidu Pharmaceutical Co. Ltd.
Segment by Type
For Injection
For Oral
Alzheimer's Disease (AD)
Arterial Hypertension
Cerebral Thrombosis
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nicergoline market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Nicergoline, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Nicergoline industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Nicergoline in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Nicergoline introduction, etc. Nicergoline Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Nicergoline market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Nicergoline report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nicergoline market is projected to reach US$ 2354.7 million in 2029, increasing from US$ 885 million in 2022, with the CAGR of 16.6% during the period of 2024 to 2029. Demand from Alzheimer's Disease (AD) and Arterial Hypertension are the major drivers for the industry.
The global nicergoline market is projected to grow steadily. The rising burden of vascular disorders worldwide will drive the demand for Nicergoline. Rising incidences of complications due to vascular disorders are anticipated to drive the demand for Nicergoline. Increasing prevalence of cerebral thrombosis, Raynaud's disease, vascular migraines, atherosclerosis, arterial blockages in the limbs, and retinopathy are projected to raise volume calls for Nicergoline. Growing FDA approval for new disease treatments is foreseen to create new growth opportunities. However, the availability of other substitutes in the market is likely to restrain the market growth. Specific challenges are roaming around the market. Adverse events have been noted associated with allergic or hypersensitivity-type reactions after the Nicergoline injection into the body. This may hinder the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nicergoline market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Teva API
FAREVA
Olon Group
Hainan Poly Pharm Co. Ltd
DEAFARMA
Solarium Pharmaceuticals
Fengchen
LGC
Pfizer Pharmaceutical Co., Ltd.
Hebei Lingding Biotechnology Co., Ltd.
Selleck Chemicals
Tocris Bioscience
Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
Shandong Fangming Pharmaceutical Group Co. Ltd.
Hainan General Kangli Pharmaceutical Co. Ltd.
Hainan Zambon Pharmaceutical Co. Ltd
Pharmacia
Shandong Qidu Pharmaceutical Co. Ltd.
Segment by Type
For Injection
For Oral
Segment by Application
Alzheimer's Disease (AD)
Arterial Hypertension
Cerebral Thrombosis
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nicergoline market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Nicergoline, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Nicergoline industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Nicergoline in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Nicergoline introduction, etc. Nicergoline Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Nicergoline market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices